Insmed Incorporated
INSM
$68.12
$0.901.34%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -63.33% | -26.60% | -38.75% | -22.79% | 1.67% |
| Total Depreciation and Amortization | 12.73% | 0.14% | -1.53% | 6.13% | 17.20% |
| Total Amortization of Deferred Charges | -0.95% | -0.13% | -11.63% | -6.34% | 4.33% |
| Total Other Non-Cash Items | 140.91% | -85.19% | 22.18% | 11.75% | -22.14% |
| Change in Net Operating Assets | -19.88% | 266.65% | 34.37% | 1,915.56% | -165.81% |
| Cash from Operations | -42.41% | -49.81% | -32.70% | -0.13% | -25.79% |
| Capital Expenditure | -115.22% | -214.54% | -29.26% | -38.91% | -37.70% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.84% | 3,401.77% | -10,096.82% | 100.00% | 566.67% |
| Cash from Investing | -72.77% | 7,207.71% | -14,140.45% | 97.53% | 609.87% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -13.69% | -158.83% | 39.74% | 33.57% | -94.06% |
| Issuance of Common Stock | 633.07% | -88.76% | 16,895.22% | 1,625.79% | 255.75% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 66.42% |
| Cash from Financing | 859.56% | 29.24% | 31,701.44% | 1,663.06% | 857.39% |
| Foreign Exchange rate Adjustments | 193.91% | -248.42% | -15.18% | 79.78% | -3,186.21% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -233.90% | 2,074.66% | -524.44% | 282.87% | 207.82% |